Small molecule drug discovery platform targeting RNA structures
At a glance
- HQ: Durham
- Sector: Biotech
- Stage: Series A
- Last round: Series A
This is the free preview.
The full profile is for members: founders, funding history, investor connections, and recent signals. Accounts are free; I review every request, usually within 48 hours.